M3 (MTHRF) Stock Analysis & Winston Score
M3, Inc. is a Japanese company that runs online platforms connecting doctors and healthcare professionals. Its flagship site, m3.com, is one of the largest physician communities in the world, with millions of registered doctors across Japan, the US, Europe, and other markets. Pharmaceutical companies use M3's platform to share drug information, conduct market research surveys, and recruit doctors for clinical trials. M3 makes money primarily by charging pharma and medical device companies for marketing services, physician surveys, and clinical trial support on its platform. It also operates in telemedicine, staffing, and healthcare IT. The massive base of registered physicians gives M3 a strong network effect — the more doctors on the platform, the more valuable it becomes to pharma clients. Key growth drivers include international expansion and AI-powered healthcare services, though the company faces risks from slower pharma marketing spending and increasing competition in digital health markets outside Japan.
Winston Score: 62/100 — Good
A decent business — some strong pillars, some weaker.
- Quality: Good (19/30)
- Growth: Good (12/20)
- Cash Flow: Weak (1/10)
- Stability: Exceptional (10/10)
- Valuation: Strong (7/10)
- Ownership: Good (10/15)
Key Facts
Price: $10.17
Market Cap: $6.8B
Sector: Healthcare
Industry: Medical - Healthcare Information Services
Exchange: Other OTC

